What is the role of anticoagulant treatment in patients with metastatic breast cancer?

Zenodo (CERN European Organization for Nuclear Research) 2026 Open access

Read full text
Authors: Tripdatabase
DOI: 10.5281/zenodo.18618468
Cited by: 0

Abstract

Anticoagulation, mainly with LMWH or DOACs, is critical in managing thrombotic risks in metastatic breast cancer, balancing efficacy against bleeding risk while considering individual treatment needs.

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Blood Coagulation and Thrombosis Mechanisms Atrial Fibrillation Management and Outcomes

Publication details

Journal / source
Zenodo (CERN European Organization for Nuclear Research)
Publication date
12 February 2026
Language
EN